MedPath

Impedancemetry in Patients Monitored for Pulmonary Hypertension

Not Applicable
Terminated
Conditions
Pulmonary Hypertension
Interventions
Device: cardiac impedancemetry
Registration Number
NCT03673774
Lead Sponsor
University Hospital, Toulouse
Brief Summary

Monocentric cohort study, prospective, evaluating the variability of cardiac output measurement by resting and stress impedancemetry as a prognostic factor for Pulmonary Hypertension

Detailed Description

Cardiac impedancemetry is a technique that allows an electrical representation of cardiac flows. To do this, 6 electrodes are applied to the thorax and a low intensity and high frequency electrical current is transmitted. The impedance is recorded and the variations of the impedance represent the changes in intra-thoracic volume and thus the volume of systolic ejection. This measurement can be done at rest but also during exercise during the walking test. A test of the NO / CO coupled transfer measurement is also performed.

The devices that will be used in this project are the Physio-Flow® system and Masterscreen NO / CO coupled transfer measurement device

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • Patient over 18 years and under 80 years
  • Patients who have been diagnosed with PAH (group 1 PH according to the Nice 2013 classification) or post-embolic pulmonary hypertension (group 4 PH) under medical treatment;
  • HTP incident or prevalent less than 6 months
  • Patient coming for follow-up or emergency consultation or hospitalization with a clinical examination and a walking test
  • Patient affiliated to a health insurance scheme
  • Patient having signed informed consent
Exclusion Criteria
  • Subjects under juridical protections or tutelage measure
  • pregnant or lactating woman
  • pulmonary hypertension du to cardiac pathology, chronic respiratory disease, or uncertain determinism.
  • pulmonary hypertension of group 4 treated surgically or endoscopically.
  • pulmonary hypertension incident or prevail for 6 months or more
  • contraindication to impedancemetry
  • inability to perform a walking test

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
cardiac impedancemetrycardiac impedancemetryMonocentric cohort study, prospective, evaluating the variability of cardiac output measurement by resting and stress impedancemetry as a prognostic factor for PH. Patients are included via the competence center of the PHP of the Midi Pyrenees region. The cardiac output is measured by impedance measurement at rest and during the walking test. The NO / CO coupled transfer measurement is performed at rest. The physician performing the consultation will not know the results of the IPC and these results will not influence the subsequent management. The patient will be followed for 18 months as part of the research.
Primary Outcome Measures
NameTimeMethod
Measure of cardiac flow variation at 6 month by impedancemetry6 month

The variation of cardiac flow is measured by impedancemetry at rest

Measure of cardiac flow variation at 0 month by impedancemetry0 month

The variation of cardiac flow is measured by impedancemetry at rest

Secondary Outcome Measures
NameTimeMethod
Measure of cardiac flow variation during walking test at 6 month6 month

The variation of cardiac flow is measured by impedancemetry during walking test

Correlation between measurement of capillary blood volume and measurement of cardiac flow6 month

Evaluate the correlation between measurement of capillary blood volume and measurement of cardiac flow by impedancemetry

Occurrence of an undesirable event18 month

Collection of undesirable event like : - Deaths (all causes combined), Hospitalization for aggravation of PAH, Progression of the disease or decrease, Unsatisfactory long-term clinical response

Measure of cardiac flow variation during walking test0 month

The variation of cardiac flow is measured by impedancemetry during walking test

Trial Locations

Locations (1)

CHU TOULOUSE hospital larrey

🇫🇷

Toulouse, Midi-Pyrennée, France

© Copyright 2025. All Rights Reserved by MedPath